OptionsHouse

Options Trading News

September 30, 2013  Mon 7:32 AM CT

ACHN: SEE CHART GET CHAIN FIND STRATEGIES

Liver Complications Won't Go Away

Achillion Pharmaceuticals said the U.S. Food & Drug Administration kept its experimental hepatitis C drug sovaprevir on hold. The company had tried to address regulators' concerns earlier in the year, but liver complications remain a problem. ACHN plunges more than 50 percent before the opening bell on my tradeMONSTER platform.

Morgan Stanley Downgrades Panera

Panera Bread was downgraded to "equal weight" from "overweight" by Morgan Stanley, which says Chipotle Mexican Grill might do a better job driving sales. PNRA falls 2 percent in the premarket and CMG inches higher.

Share this article with your friends


Related Stories

ACHN

Huge bullish volume in Achillion

May 19, 2015

The developer of Hepatitis C drugs shot higher yesterday after canceling its appearance at a UBS conference, raising speculation that it is a potential buyout candidate.

OptionsHouse

TRADING WEEKLY OPTIONS

The fastest money in the market
View full report »

Premium Services

Archived Webinar

Education & Strategy

Long synthetic call

Long and short Synthetic stock are two of the six basic synthetic positions that exist. Number three on our list is the Synthetic Long Call...

View more education articles »